REPLIGEN CORP — Director's Dealing 2019

Jun 12, 2019

SEC Form 4/A — Form 4/A

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2019-02-28

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Option (Right to Buy)	$59.52	A	21756	Acquired	2019-02-28	Common Stock (21756)	Direct

Footnotes

F1: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022